Find out more about the performance of the Novo Nordisk share - expert forecasts, current developments and balance sheet preview.
According to a report from www.finanzen.net, Novo Nordisk shares increased in value on Thursday afternoon and are among the best performers of the day. The share recently rose by 0.1 percent to EUR 99.09 in the Tradegate meeting. The Novo Nordisk share briefly reached a new daily high of EUR 99.73, which is also the 52-week high. The average price targets of analysts are DKK 1,217.50 and the next financial statement is expected on January 31, 2024. Experts expect EPS to amount to DKK 18.37 per share in 2023. Based on this information, it can be seen that Novo Nordisk shares are currently trending positively...

Find out more about the performance of the Novo Nordisk share - expert forecasts, current developments and balance sheet preview.
According to a report by www.finanzen.net, Novo Nordisk shares increased in value on Thursday afternoon and are among the best performers of the day. The share recently rose by 0.1 percent to EUR 99.09 in the Tradegate meeting.
The Novo Nordisk share briefly reached a new daily high of EUR 99.73, which is also the 52-week high. The average price targets of analysts are DKK 1,217.50 and the next financial statement is expected on January 31, 2024. Experts expect EPS to amount to DKK 18.37 per share in 2023.
Based on this information, it can be seen that Novo Nordisk shares are currently trending positively. The 52-week high suggests strong performance, while analysts' average price targets are optimistic. This could attract long-term investors as positive EPS forecasts indicate a good future outlook. Overall, Novo Nordisk shares currently appear to be attractive for investors.
Read the source article at www.finanzen.net